Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SCAR-02 by Hunan Siweikang Therapeutics for Rheumatoid Arthritis: Likelihood of Approval
SCAR-02 is under clinical development by Hunan Siweikang Therapeutics and currently in Phase II for Rheumatoid Arthritis. According to GlobalData,...